Turmeric and the role of inflammation and managing depression: a randomised, double blind, placebo controlled trial

Methods: In a recent randomised, double-blind, placebo-controlled study supported by Health World Ltd, 56 individuals with major depressive disorder were treated with BCM-95® turmeric (25g turmeric per day) or placebo for eight weeks.

Results: Statistically significant improvements in mood were seen in the treatment group after four and eight weeks.

Discussion/Conclusions: While much is gained from traditional knowledge of herbal medicines, scientific research offers additional contributions including investigating novel mechanisms, as seen in this study. With approximately one third of patients with depression unresponsive to conventional antidepressant therapies, this is a critical area of research. BCM-95® turmeric, through its actions in attenuating inflammation, is an effective treatment for the management of major depression.

‍